Project FluCov


Duration: 2021 - ongoing
FluCov: monitoring and communicating the impact of COVID-19 on influenza activity and assessing future influenza epidemics scenarios

PijnRationale

On 1 January 2020, the World Health Organisation (WHO) requested information on a reported cluster of atypical pneumonia cases in Wuhan from the Chinese authorities. On 1 March 2020, WHO made the assessment that SARS-CoV-2 could be characterized as a pandemic. The emergence of this new virus has had a major impact on the global circulation of respiratory viruses, including influenza and RSV (see https://www.nature.com/articles/s41467-022-29402-5).

Doel Aim

The aim of the research project is to document and communicate about:

  • the impact of the SARS-CoV-2 pandemic on influenza activity
  • modelling future epidemic scenarios, with a focus on influenza activity
  • the measures to prevent and control influenza in the coming years (e.g. by vaccination).

Nivel ZorgregistratiesParticipating countries

A number of 22 contextual and geographical representative countries have been selected:

  • Africa (2): Egypt, South-Africa
  • America (4): Brazil, Canada, Mexico, USA
  • Europe (8): France, Germany, Israel, Italy, Netherlands, Poland, Spain, United Kingdom
  • South Asia (4): India, Philippines, Thailand, Vietnam
  • Pacific (5): Australia, China, Japan, South Korea, Taiwan

Producten en dienstenProject design

The research project consists of four components:

  1. establish a procedure to access and publish routine influenza (FluNet data) and SARS-CoV-2 surveillance data
  2. implement a testing and laboratory practices survey of National Influenza Centres to assess how SARS-CoV-2 has impacted influenza surveillance capacity
  3. collect influenza vaccination coverage rates in the selected countries (by risk group)
  4. In collaboration with colleagues at EHESP, develop and apply a modelling strategy to produce scenarios on the possible resurgence of influenza activity in the coming years

ResultatenResult: FluCov Dashboard, the impact of SARS-CoV-2 on influenza
 

Nivel-FluCov-Dashboard

The emergence of SARS-CoV-2 in 2019 had a major impact on the global circulation of respiratory viruses, including influenza (see https://www.nature.com/articles/s41467-022-29402-5). In order to understand the impact of SARS-CoV-2 on influenza activity worldwide, the FluCov Dashboard offers users a clear view of the current and past circulation of both viruses (since 2019), in a wide range of countries all over the world. Real-time weekly surveillance weekly data are downloaded and presented in the Dashboard.

ResultatenResults: publications

We share our research and findings by providing access to the FluCov Bulletins, posters, and survey results:

  1. regular publication of the FluCov Bulletin: an epidemiological assessment of the impact of SARS-CoV-2 on influenza activity
  2. creation of a dashboard which allows visitors to query the influenza and Sars-Cov-2 data themselves
  3. an abstract regarding the epidemiological impact of the SARS-CoV-2 pandemic on influenza activity, which was submitted to ESCAIDE (European Scientific Conference on Applied Infectious Disease Epidemiology) in November 2021
  4. two abstracts which were submitted to Options XI: 1) the NIC survey results and 2) the modelling study/strategy (by EHESP)
FluCov-Bulletins (starting in June 2021)
InFluNews (Newsletter Global Influenza Initiative GII)
Posters
  • FluCov EpiBulletin, presented at WHO-ISIRV conference "COVID-19, Influenza and RSV: Surveillance-Informed Prevention and Treatment, 19-21 October 2021
  • FluCov NIC Survey, presented at OPTIONS XI, 26-29 September 2022
  • EU5 Modelling to produce influenza activity scenarios, presented at OPTIONS XI, 26-29 September 2022
Scientific publications
Presentations
  • GII-MENA-RAISE Survey – Results
Reports

Panels met patiënten, cliënten en burgersNivel project team

Participating Nivel researchers are:

SamenwerkingsverbandProject partners

  • The Global Influenza Initiative (GII) 
  • École des Hautes Etudes en Santé Publique (EHESP)

    SterFunding

    The research project is funded by Sanofi. The current research grant runs until 31 July 2023.

Meer wetenWant to know more?

For more information on this project, please feel free to get in touch with the Nivel expert(s) involved. You will find them on the right, together with the (future) Nivel deliverables (publications) and other relevant content.

 

Paget, J. Project FluCov . From: www.nivel.nl [Last update 23-January-2023; consulted on 01-February-2023]. URL: https://www.nivel.nl/en/dossier-epidemiology-respiratory-viruses/project-flucov